Apo-Mycophenolic Acid 360 mg (Mycophenolic Acid (Mycophenolate Sodium) TABLET (ENTERIC-COATED)) 360 MG

APO-MYCOPHENOLIC ACID 360 MG is an enteric-coated tablet used to prevent organ rejection after transplants. This medication contains mycophenolic acid, a potent immunosuppressant. Learn more about its uses and effects.

Strength

360 MG

Pack Size

120

Manufacturer / TM Owner

APOTEX INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

APO-MYCOPHENOLIC ACID 360 MG is primarily used to prevent rejection in organ transplant patients. It works by suppressing the immune system to help the body accept the new organ. This medication is often prescribed as part of a broader treatment plan. What is mycophenolic acid used for? It is used to maintain organ function post-transplant by reducing the immune response.

Side Effects

Common effects of APO-MYCOPHENOLIC ACID 360 MG may include gastrointestinal discomfort, such as diarrhea or nausea. Some users might experience fatigue or an increased risk of infections due to its immunosuppressant properties. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Handle APO-MYCOPHENOLIC ACID 360 MG with care, as it can increase the risk of infections and other complications. Avoid activities that require alertness until you know how the medication affects you. Store in a cool, dry place away from children and pets.

Avoid Interactions

APO-MYCOPHENOLIC ACID 360 MG may interact with other medications, including antacids and certain antibiotics. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol should be avoided as it may exacerbate side effects.

Frequently Asked Questions

APO-MYCOPHENOLIC ACID 360 MG is used to prevent organ rejection in transplant patients by suppressing the immune system.

APO-MYCOPHENOLIC ACID 360 MG should be taken orally, typically with water, as directed by a healthcare provider.

Common side effects may include gastrointestinal discomfort, fatigue, and an increased risk of infections.

APO-MYCOPHENOLIC ACID 360 MG may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Store APO-MYCOPHENOLIC ACID 360 MG in a cool, dry place away from children and pets.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.